Α-מבחן: ראפיד נייד ללא ספירת CD4 באמצעות הרוק שלם
Summary
שיטת ספירת CD4, α-הבדיקה, מתואר אשר עושה שימוש הרוק כולו לספק מהיר ומדויק ספירת CD4. את α-הבדיקה עולה פרוטות ומונע את הצורך טכניים, חומרים כימיים אימונים יקרים כגון נוגדנים חד שבטיים, מכשור, קירור, הובלה של דגימות, וכן איסוף וטיפול של דם.
Abstract
There is an urgent need for affordable CD4 enumeration to monitor HIV disease. CD4 enumeration is out of reach in resource-limited regions due to the time and temperature restrictions, technical sophistication, and cost of reagents, in particular monoclonal antibodies to measure CD4 on blood cells, the only currently acceptable method. A commonly used cost-saving and time-saving laboratory strategy is to calculate, rather than measure certain blood values. For example, LDL levels are calculated using the measured levels of total cholesterol, HDL, and triglycerides1. Thus, identification of cell-free correlates that directly regulate the number of CD4+ T cells could provide an accurate method for calculating CD4 counts due to the physiological relevance of the correlates.
The number of stem cells that enter blood and are destined to become circulating CD4+ T cells is determined by the chemokine CXCL12 and its receptor CXCR4 due to their influence on locomotion2. The process of stem cell locomotion into blood is additionally regulated by cell surface human leukocyte elastase (HLECS) and the HLECS-reactive active α1proteinase inhibitor (α1PI, α1antitrypsin, SerpinA1)3. In HIV-1 disease, α1PI is inactivated due to disease processes 4. In the early asymptomatic categories of HIV-1 disease, active α1PI was found to be below normal in 100% of untreated HIV-1 patients (median=12 μM, and to achieve normal levels during the symptomatic categories4, 5. This pattern has been attributed to immune inactivation, not to insufficient synthesis, proteolytic inactivation, or oxygenation. We observed that in HIV-1 subjects with >220 CD4 cells/μl, CD4 counts were correlated with serum levels of active α1PI (r2=0.93, p<0.0001, n=26) and inactive α1PI (r2=0.91, p<0.0001, n=26) 5. Administration of α1PI to HIV-1 infected and uninfected subjects resulted in dramatic increases in CD4 counts suggesting α1PI participates in regulating the number of CD4+ T cells in blood 3.
With stimulation, whole saliva contains sufficient serous exudate (plasma containing proteinaceous material that passes through blood vessel walls into saliva) to allow measurement of active α1PI and the correlation of this measurement is evidence that it is an accurate method for calculating CD4 counts. Briefly, sialogogues such as chewing gum or citric acid stimulate the exudation of serum into whole mouth saliva. After stimulating serum exudation, the activity of serum α1PI in saliva is measured by its capacity to inhibit elastase activity. Porcine pancreatic elastase (PPE) is a readily available inexpensive source of elastase. PPE binds to α1PI forming a one-to-one complex that prevents PPE from cleaving its specific substrates, one of which is the colorimetric peptide, succinyl-L-Ala-L-Ala-L-Ala-p-nitroanilide (SA3NA). Incubating saliva with a saturating concentration of PPE for 10 min at room temperature allows the binding of PPE to all the active α1PI in saliva. The resulting inhibition of PPE by active α1PI can be measured by adding the PPE substrate SA3NA. (Figure 1). Although CD4 counts are measured in terms of blood volume (CD4 cells/μl), the concentration of α1PI in saliva is related to the concentration of serum in saliva, not to volume of saliva since volume can vary considerably during the day and person to person6. However, virtually all the protein in saliva is due to serum content, and the protein content of saliva is measurable7. Thus, active α1PI in saliva is calculated as a ratio to saliva protein content and is termed the α1PI Index. Results presented herein demonstrate that the α1PI Index provides an accurate and precise physiologic method for calculating CD4 counts.
Protocol
Discussion
הסרום מכיל חי חציון 36 מיקרומטר α 1 PI ו 3.6 מיקרומטר α 2 macroglobulin (α 2 מ ') 10 הפרש של פי 8. שני חלבונים להתחרות על קשירה PPE. שני מאפיינים אלה, הריכוז PPE זיקה, נוצלו לפתח שיטה כי הוא מסוגל במיוחד למדידת α 1 PI בסרום נורמלי בנוכחות מתחרים α 2 מ …
Divulgazioni
The authors have nothing to disclose.
Acknowledgements
המחקר נתמך על ידי קרן המחקר הארי וינסטון.
Materials
| Name of the reagent | Company | Catalogue number |
| Sialogogue, 0.05M citric acid | Eda’s Sugarfree Candies, 4900 Rear N.20th Street, Philadelphia, PA 19144 | Sugar-Free Lemon dropS |
| Porcine pancreatic elastase, type 1 (EC 3.4.21.36) | Sigma-Aldrich, St. Louis, MO 63103 | E1250 |
| Succinyl-L-Ala-L-Ala-L-Ala-p-nitroanilide | Sigma-Aldrich | S4760 |
| Coomassie Brilliant Blue R-250 | Sigma-Aldrich | B7920 |
| Tissue culture-treated, 96 well microplates | Becton Dickinson, Franklin Lakes, NJ 07417-1886 | 35-3072 |
| Microplate Reader with filters for 405 nm and 595 nm | MTX Lab Systems, 8456 Tyco Road, Building D, Vienna, Virginia 22182 | Dynex P97277 |
Riferimenti
- Friedlander, Y., Kark, J. D., Eisenberg, S., Stein, Y. Calculation of LDL-cholesterol from total cholesterol, triglyceride and HDL-cholesterol: a comparison of methods in the Jerusalem Lipid Research Clinic Prevalence Study. Isr. J. Med. Sci. 18, 1242-1252 (1982).
- Lapidot, T., Petit, I. Current understanding of stem cell mobilization: The roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp. Hematol. 30, 973-981 (2002).
- Bristow, C. L., Alfano, M. α1Antitrypsin therapy increases CD4+ lymphocytes to normal values in HIV-1 patients. Soluble factors mediating innate immune responses to HIV infection. , (2010).
- Bristow, C. L., Patel, H., Arnold, R. R. Self antigen prognostic for human immunodeficiency virus disease progression. Clin. Diagn. Lab. Immunol. 8, 937-942 (2001).
- Bristow, C. L., Babayeva, M. A., LaBrunda, M., Mullen, M. P., Winston, R. α1Proteinase Inhibitor regulates CD4+ lymphocyte levels and is rate limiting in HIV-1 disease. PLoS One. , (2011).
- de Almeida, P. D. V., Gregio, A. M. T., Machado, M. A. N., de Lima, A. A. S., Azevedo, L. R. Saliva Composition and Functions: A Comprehensive Review. J. Contemp. Dent. Pract. 9, 72-80 (2008).
- Edgar, W. M. Saliva: its secretion, composition and funcitons. Br. Dent. J. , 172-305 (1992).
- Bristow, C. L., Meo, F. d. i., Arnold, R. R. Specific activity of α1proteinase inhibitor and 2macroglobulin in human serum: Application to insulin-dependent diabetes mellitus. Clin. Immunol. Immunopathol. 89, 247-259 (1998).
- Pederson, E. D. Salivary levels of α2-macroglobulin, α1-antitrypsin, C-reactive protein, cathepsin G and elastase in humans with or without destructive periodontal disease. Arch. Oral Biol. 40, 1151-1155 (1995).
- Shak, S., Capon, D. J., Hellmiss, R., Marsters, S. A., Baker, C. L. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. PNAS. 87, 9188-9192 (1990).
- LeVeque, F. G. A multicenter, randomized, double-blind, placebo-controlled, dose- titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J. Clin. Oncol. 11, 1124-1131 (1993).
- Stevens, W. Evaluating new CD4 enumeration technologies for resource-constrained countries. Nat. Rev. Microbiol. 6, S29-S38 (2008).
- WHO. . 2010 ART guidelines for adults and adolescents – evidence map. , (2010).
